Related references
Note: Only part of the references are listed.Intron retention in mRNA: No longer nonsense Known and putative roles of intron retention in normal and disease biology
Justin J. -L. Wong et al.
BIOESSAYS (2016)
Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation
I. Tinhofer et al.
ANNALS OF ONCOLOGY (2016)
Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation
I. Tinhofer et al.
EUROPEAN JOURNAL OF CANCER (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome
Thomas Kraemer et al.
STEM CELLS INTERNATIONAL (2015)
HLA-G: An Immune Checkpoint Molecule
Edgardo D. Carosella et al.
ADVANCES IN IMMUNOLOGY, VOL 127 (2015)
Widespread intron retention in mammals functionally tunes transcriptomes
Ulrich Braunschweig et al.
GENOME RESEARCH (2014)
In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance
Laure Loumagne et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Molecular Genetics of Clear-Cell Renal Cell Carcinoma
James Brugarolas
JOURNAL OF CLINICAL ONCOLOGY (2014)
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
Marco Gerlinger et al.
NATURE GENETICS (2014)
Variation in genomic landscape of clear cell renal cell carcinoma across Europe
Ghislaine Scelo et al.
NATURE COMMUNICATIONS (2014)
Cytoplasmic intron retention, function, splicing, and the sentinel RNA hypothesis
Peter T. Buckley et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2014)
Synthetic HLA-G proteins for therapeutic use in transplantation
Joel LeMaoult et al.
FASEB JOURNAL (2013)
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
Daehwan Kim et al.
GENOME BIOLOGY (2013)
MiRNA-Mediated Control of HLA-G Expression and Function
Irit Manaster et al.
PLOS ONE (2012)
KIR2DL4 (CD158d). an activation receptor for HLA-G
Sumati Rajagopalan et al.
FRONTIERS IN IMMUNOLOGY (2012)
Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17
Sophie Agaugue et al.
BLOOD (2011)
p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage
M. Aoubala et al.
CELL DEATH AND DIFFERENTIATION (2011)
Human leukocyte antigen-G in the male reproductive system and in seminal plasma
Margit Horup Larsen et al.
MOLECULAR HUMAN REPRODUCTION (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms A NOVEL THERAPEUTIC STRATEGY FOR ANGIOGENESIS
Dawid G. Nowak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer-Preclinical Background: CTLA-4 and PD-1 Blockade
Jeffrey Weber
SEMINARS IN ONCOLOGY (2010)
The Isoforms of the p53 Protein
Marie P. Khoury et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites
Inhan Lee et al.
GENOME RESEARCH (2009)
RNA-Seq: a revolutionary tool for transcriptomics
Zhong Wang et al.
NATURE REVIEWS GENETICS (2009)
Molecular Diversity of VEGF-A as a Regulator of Its Biological Activity
Jeanette Woolard et al.
MICROCIRCULATION (2009)
Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors
Hilary L. Hoare et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera
C. Menier et al.
LEUKEMIA (2008)
Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals
XH Xie et al.
NATURE (2005)
Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function
T Gonen-Gross et al.
JOURNAL OF IMMUNOLOGY (2003)
Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters
CS Lin et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2002)
Renal epithelial neoplasms: The diagnostic implications of electron microscopic study in 55 cases
B Krishnan et al.
HUMAN PATHOLOGY (2002)
HLA-G2,-G3, and-G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis
B Riteau et al.
JOURNAL OF IMMUNOLOGY (2001)
HLA-G and HLA-E: fundamental and pathophysiological aspects
ED Carosella et al.
IMMUNOLOGY TODAY (2000)
Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells
P Paul et al.
HUMAN IMMUNOLOGY (2000)
HLA-G, -E, -F preworkshop: Tools and protocols for analysis of non-classical class I genes transcription and protein expression
P Paul et al.
HUMAN IMMUNOLOGY (2000)
Hyaline globules in renal cell carcinoma and hepatocellular carcinoma - A clue or a diagnostic pitfall on fine-needle aspiration?
R Nayar et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2000)